StockData
Sera Prognostics, Inc. logo

Sera Prognostics, Inc. (SERA) stock

SERANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/30
$1.98+0.04 (+2.06%)

Close on Nov 12, 2026Market cap $78.11MP/E –Yield –

Sera Prognostics enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Sera Prognostics's enterprise value was $50.68M on Nov 11, 2026, against $101.97M a year earlier. Over the last 4 years it ranged from -$73.56M to $315.66M, with a median of $57.55M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$50.68M-40.6%
2025Dec 31, 2025$85.39M-60.3%
2024Dec 31, 2024$214.99M+53.7%
2023Dec 29, 2023$139.86M–
2022Jan 31, 2022-$68.51M–
2021Dec 31, 2021-$67.59M–

More Sera Prognostics figures

See a number that looks wrong?